Recently, several studies have been conducted to evaluate the role of common tumor markers CEA, CA19-9, CA-125 and AFP in the diagnosis, prognosis and postoperative recurrence detection of patients with CRLMs 11-13,15,16. The gene discussed is CEACAM5; the disease is neoplasm.